BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Azathioprine

An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)

300+ PubMed studies analyzed · 33 RCTs · Evidence Score: 52.6

Research Domains

Azathioprine has been studied across 14 research domains including 🛡️ Immunity, 🫁 Liver & Detox, ✨ Skin & Hair, 🫘 Kidney, 🔬 Oncology. The primary research focus is 🛡️ Immunity with 58% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Azathioprine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Melphalan
20 shared targets
Betamethasone
14 shared targets
Thioinosine
13 shared targets
Polidocanol
15 shared targets
Nitrofurazone
15 shared targets
clofilium
17 shared targets
Ethynodiol
16 shared targets
Levonorgestrel
16 shared targets
Norgestrel
16 shared targets
Melengestrol
13 shared targets
Loading evidence profile...

This evidence profile for Azathioprine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.